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Background: We investigated the molecular epidemiological characteristics and antimi-
crobial susceptibility pattern of penicillinase-producing Neisseria gonorrhoeae (PPNG) 
isolates to monitor the change in distribution of blaTEM in Korea. 
Methods: We collected 804 PPNG isolates from diverse hospitals and clinics mainly lo-
cated in Seoul, Korea, over a period of 11 years (2005–2015). Isolate susceptibility to seven 
antimicrobials was determined using the agar dilution test. The molecular epidemiological 
characteristics of the isolates were determined by Sanger sequencing of blaTEM, N. gonor-
rhoeae multiantigen sequence typing (NG-MAST) and plasmid typing.
Results: Among 72 fully sequenced PPNG isolates, sixteen (22.2%) possessed TEM-135. 
All TEM-135 isolates had a common silent mutation (c.18C>T), which was previously un-
reported. We observed a pattern of continuous increase in the number of TEM-135 iso-
lates since 2012. The median and 90% minimum inhibitory concentration of azithromycin 
were substantially lower in the TEM-135 group than in the non-PPNG and TEM-1 groups. 
All TEM-135 isolates showed different NG-MAST types and predominantly harbored To-
ronto/Rio (75%) plasmids. A comprehensive comparative analysis of PPNG with TEM-135 
according to NG-MAST, plasmid type, and year of isolation revealed a wide distribution.
Conclusions: The proportion of TEM-135 PPNG has continuously increased since 2012, 
in association with clonal spread. The difference at position 18 of the TEM-135 sequence 
can be interpreted as the existence of multiple clonal complexes. The possibility that TEM-
135 was acquired via foreign plasmids requires careful follow-up and continuous monitor-
ing of TEM-135 to ascertain whether it constitutes a step towards evolutionary change. 
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INTRODUCTION
Penicillin treatment failure was first reported soon after the intro-
duction of penicillin administration in the 1940s; dissemination 
of penicillin resistance has made this antibiotic useless since 
the 1950s [1]. The mechanism of penicillin resistance prevalent 
during the 1960s and mid-1970s is associated with mutations 
in chromosomal genes (mainly penA gene) encoding for penicil-
lin binding proteins (chromosomally-mediated penicillin resis-
tant N. gonorrhoeae, CMRNG) [1, 2]. Although CMRNG resulted 
in clinical treatment failure, administration of high-dose penicil-
lin remained effective against CMRNG until a new resistance 
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mechanism emerged in 1976 [3]. This novel mechanism re-
sulted from the acquisition of a plasmid-located β-lactamase 
gene (blaTEM-1) exhibiting high-level resistance to penicillin (peni-
cillinase-producing N. gonorrhoeae, PPNG). Wide dissemina-
tion of PPNG ultimately provoked the usage of extended-spec-
trum cephalosporin antibiotics, including ceftriaxone and cefix-
ime, which were effective against the TEM-1 β-lactamase with a 
narrow hydrolytic spectrum [4, 5]. However, there have been 
frequent recent reports of new β-lactamase variants sharing com-
mon single nucleotide polymorphisms (compared with TEM-1).
TEM-135, which has a single amino acid change (M182T) 
compared with the TEM-1 sequence, was first reported in 2005 
[6], and its frequency and genetic diversity have been consis-
tently evaluated in many countries. The clinical significance of 
TEM-135 remains unclear, as there are no major differences in 
the minimal inhibitory concentrations (MICs) of penicillin and 
extended-spectrum cephalosporins; however, the emergence of 
TEM-135 could signify the introduction of other TEM β-lactamases 
with an extended β-lactam hydrolytic spectrum through muta-
tion or plasmid acquisition under the high selective pressure of 
cephalosporin usage. We aimed to determine the prevalence of 
TEM-135 and compare the characteristics of TEM-1- and TEM-
135-producing N. gonorrhoeae isolated in Korea from 2005 to 
2015.
METHODS
1. N. gonorrhoeae isolates
A total of 804 isolates were collected over 11 years (2005–2015) 
from 40 diverse hospitals and primary-care clinics in Korea to 
test for the presence of the TEM-135 gene. This study was ap-
proved by the Institutional Review Board of the Human Research 
Protection Center in the Yonsei University Health System (4-2016-
0359). Transgrow medium was used as the transport medium 
to minimize the loss of viable N. gonorrhea isolates, and modi-
fied Thayer-Martin medium (Becton-Dickinson, Cockeysville, 
MD, USA) was used for colony growth and incubation. Bacterial 
identification was confirmed by Gram-stain and the Vitek system 
(bioMerieux, Marcy l’Etoile, France) or by matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) mass spec-
trometry (Bruker Daltonics, Bremen, Germany). All isolates were 
collected for the national surveillance program for gonococci 
supported by the Korean Centers for Disease Control and Pre-
vention. They were stored at –70°C until the number of isolates 
collected was sufficient for analysis. Molecular analysis was per-
formed.
2.  Antimicrobial susceptibility testing and examination of 
β-lactamase production
The antimicrobial susceptibility of all isolates to the antibiotics 
(penicillin G, tetracycline, ceftriaxone, spectinomycin, ciproflox-
acin, nalidixic acid, and azithromycin) was determined using 
the CLSI disk diffusion method [7]. MIC was calculated using 
the agar dilution test according to the CLSI guidelines [8] for all 
antibiotics except azithromycin, for which the European Com-
mittee on Antimicrobial Susceptibility Testing (EUCAST) cut-off 
values were used [9]. The median and 90% MIC values (MIC50 
and MIC90) and range were evaluated for the three groups of 
isolates: non-PPNG, PPNG with TEM-1, and PPNG with TEM-
135.
3.  DNA extraction and mismatch amplification mutation 
assay polymerase chain reaction
DNA was extracted from PPNG bacterial suspensions, using the 
QIAquick gel extraction kit (Qiagen, Hilden, Germany). Mismatch 
amplification mutation assay (MAMA) PCR was performed to 
detect the blaTEM-135 allele, and TEM PCR was performed to iden-
tify both blaTEM-1 and blaTEM-135 [10]. The complete blaTEM sequen-
ces of PPNG isolates were confirmed by Sanger sequencing 
based on a comparison between the TEM-135 reference se-
quence (GenBank accession number: GQ896333) and the PCR 
products.
4.  Molecular epidemiology of TEM-135 isolates using N. 
gonorrhoeae multiantigen sequence typing (NG-MAST) 
and plasmid typing
To evaluate the molecular epidemiology of the TEM-135 iso-
Fig. 1. Chronological changes in the percentage of isolates with 
TEM-1 or TEM-135 β-lactamase among all the N. gonorrhoeae iso-
lates collected between 2005 and 2015. 
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Table 1. Alterations in the nucleic acid and amino acid sequences of TEM-1 and TEM-135 β-lactamase
Species (GenBank accession number)
TEM  
subtypes
Position of nucleic acid alteration (amino acid alteration)
18 (Silent)  
Wild type: T,  
Mutant: C
539 (Met182Thr)  
Wild type: T,  
Mutant: C
547 (Ala185Thr)  
Wild type: G,  
Mutant: A
N. gonorrhoeae (AG) TEM-1 T T G
Salmonella enerica subsp. enterica serovar Typhimurium (AJ634602) TEM-135 T C G
N. gonorrhoeae (GQ896333, Thailand) TEM-135 C C G
N. gonorrhoeae (AB551787, Japan) TEM-135 T C G
N. gonorrhoeae (KM998962) TEM-220 T C A
N. gonorrhoeae isolates with TEM-135 in this study TEM-135 T C G
Nucleotides written in boldface are mutated nucleotides.
Table 2. Comparison of resistance proportion and antibiotic geometric mean MIC values according to the presence of TEM-1 or TEM-135
Antibiotics
MIC (µg/mL) Antimicrobial susceptibility (%)
Range MIC50 MIC90 Susceptible Intermediate Resistant
TEM-1 PPNG (N=38)*
Penicillin 2–256 64 128 0 0 100
Ceftriaxone ≤0.008–0.12 0.03 0.12 100 0
Cefixime ≤0.008–0.25 0.03 0.12 100 0
Spectinomycin 16–32 32 32 100 0 0
Tetracycline 0.25–128   4 32 9.4 12.5 78.1
Ciprofloxacin 0.06–32   2 16 3.1   6.3 90.6
Azithromycin† ≤0.06–8 0.25   1 60.0 24.0 16.0
TEM-135 PPNG (N=14)‡
Penicillin 32–256 128 128 0 0 100
Ceftriaxone ≤0.008–0.06 ≤0.008 ≤0.008 100 0
Cefixime ≤0.008–0.06 ≤0.008 ≤0.008 100 0
Spectinomycin 8–32 32 32 100 0 0
Tetracycline 0.25–32 0.5 32 15.4 53.8 30.8
Ciprofloxacin ≤0.008–8 2   4 15.4 0 84.6
Azithromycin† ≤0.06–0.25 0.06 0.25 100 0 0
Non-PPNG (N=529)
Penicillin ≤0.06–32 1 4 0 61.5 38.5
Ceftriaxone ≤0.008–0.25 0.03 0.12 100 0
Cefixime ≤0.008–0.5 0.03 0.25 96.6 3.4
Spectinomycin ≤4–32 32 32 100 0 0
Tetracycline ≤0.12–128   2 32 3.0 31.0 66.0
Ciprofloxacin ≤0.008–64   8 16 12.3   3.7 84.0
Azithromycin† ≤0.06–4 0.25 0.5 57.2 35.2   7.6
*Of the 56 TEM-1 PPNG isolates, 38 isolates were available for antimicrobial susceptibility testing with all seven antibiotics; †EUCAST cut-off values were uti-
lized because there are no recommended cut-off values in CLSI M100-S25; ‡Of the 16 TEM-135 PPNG isolates, 14 isolates were available for antimicrobial 
susceptibility testing with all seven antibiotics.
Abbreviations: MIC, minimum inhibitory concentration; MIC50, median MIC; MIC90, 90% MIC; PPNG, penicillinase-producing N. gonorrhoeae.
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lates, NG-MAST was performed by sequencing the porB and 
tbpB genes; allele numbers and sequence types (STs) were as-
signed using the NG-MAST website (http://www.ng-mast.net), 
as previously described [11]. For plasmid typing, multiplex PCR 
was performed on all isolates, as previously described, using 
primers BL1, BL2, BL3, and BL4 [12].
RESULTS
1. Detection and trends of PPNG isolates with TEM-135 
PPNG isolates accounted for 11.6% (N=93) of the 804 isolates, 
with patterns fluctuating by collection year (Fig. 1). Only 72 PPNG 
isolates (77.4%) were available for further molecular investiga-
tion because of loss or deterioration of the isolates during the 
storage period. These 72 isolates were subjected to full sequence 
analysis to determine the presence of TEM-1 or TEM-135; 22.2% 
(N=16) were shown to harbor TEM-135. The first TEM-135 iso-
late was identified in 2006, and the number of TEM-135 isolates 
has continuously increased since 2012. Although no variant 
types other than TEM-1 and TEM-135 were found, all isolates 
possessed a silent mutation, c.18C>T, which does not change 
the original amino acid (Proline) compared with the previously 
reported blaTEM-135 reference sequence (GQ896333; Table 1). 
2.  Antimicrobial susceptibility of PPNG isolates with or 
without TEM-135
Of the 72 PPNG isolates, 52 (38 TEM-1 and 14 TEM-135 iso-
lates) were randomly selected (mainly because of strain avail-
Fig. 2. Genetic distance tree and plasmid types of penicillinase-producing Neisseria gonorrhoeae with TEM-1 or TEM-135 grouped accord-
ing to porB genotype. Alleles marked with a black circle or numbers shown in red are associated with isolates harboring TEM-135; num-
bers in parenthesis indicate the number of isolates with the same sequence type. Although sequence types are diverse among isolates with 
TEM-135, two small clusters (cluster A and B) accounting for 56.3% (9/16) of all TEM-135 isolates appear to be independently segregated.
Abbreviation: NG-MAST, Neisseria gonorrhoeae multiantigen sequence typing; ST, sequence type; AF, African; AS, Asian; TR, Tronto/Rio.
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ability) for antimicrobial susceptibility testing with seven antibiot-
ics. The proportions of susceptible isolates for the seven antibi-
otics were similar between the TEM-1 group and TEM-135 group, 
whereas the non-PPNG group showed a different pattern (Table 
2). Comparison of the MIC50 and MIC90 (determined using the 
agar dilution test) of the three groups (non-PPNG, PPNG with 
TEM-1, and PPNG with TEM-135) showed that the MIC50 and 
MIC90 of ceftriaxone and cefixime were significantly lower in the 
TEM-135 than in the other groups (all values ≤0.008 μg/mL). 
Additionally, the MIC50 and MIC90 of azithromycin in the TEM-135 
group were also lower than those in the TEM-1 group (MIC50 = 
0.06 µg/mL and MIC90 =0.25 µg/mL for the TEM-135 group). 
No significant changes in antimicrobial resistance trends were 
observed in the TEM-1, TEM-135, and non-PPNG groups (Sup-
plemental Data Table S1).
3.  Determination of molecular epidemiological 
characteristics by NG-MAST and plasmid typing
The STs of 72 PPNG isolates were determined by NG-MAST in 
order to elucidate the molecular epidemiology of plasmids pos-
sessing certain types of penicillinases; 59 different STs were iden-
tified, indicating heterogeneous epidemiological distribution (Fig. 
2). The STs bearing TEM-135 were dispersed throughout the 
genetic tree (generated based on por gene sequences using the 
unweighted pair group method with arithmetic mean [UPGMA] 
approach), except for two small clusters (cluster A and B; Fig. 
2). Plasmid typing of all PPNG isolates demonstrated that the 
African plasmid type was the most common type, present in 51/72 
isolates (70.8%), followed by the Toronto/Rio (N=13, 18.1%) 
and the Asian (N=8, 11.1%) plasmid types. However, among 
the TEM-135 isolates, the Toronto/Rio plasmid type was predo-
minant (N=13, 81.3%), followed by the Asian (N=2, 12.5%) 
and the African (N=1, 6.2%) plasmid types. ST3965 isolates all 
possessed TEM-1 on an African type plasmid, except for one 
isolate with TEM-135 on a Toronto/Rio type plasmid. In cluster 
A, five TEM-135 isolates (designated with black dots and bold 
red numbers; blue box, Fig. 2) appeared to be closely related 
based on close genetic distances (determined by NG-MAST), 
the predominance of the Toronto/Rio type (established by plas-
mid typing), and recent isolation (within the last three years). 
Four isolates in cluster B (Fig. 2) harbored three Toronto/Rio 
plasmids and one Asian plasmid. Interestingly, the Asian and 
African plasmids bearing TEM-135 have appeared recently (in 
2012, 2014, and 2015).
DISCUSSION
The emergence of PPNG was one reason for the use of extended-
spectrum cephalosporins, including ceftriaxone and cefixime; 
the appearance of TEM-135 could constitute another turning 
point in gonococcal treatment through the evolution or introduc-
tion of novel β-lactamases to N. gonorrhoeae. Following the first 
report of TEM-135 in Japan, the reported prevalence of TEM-
135 ranged from 9.4% to 57.8% according to country [10, 13-
17]. The average prevalence of TEM-135 in our study was 22.2% 
over a period of 11 years (2005–2015). Although the prevalence 
trends showed fluctuations, a pattern of continuous increase in the 
proportion of TEM-135 is observed in the last four years (2012–
2015). 
The antimicrobial susceptibility patterns of ceftriaxone, cefix-
ime, azithromycin, and tetracycline in PPNG with TEM-135 dif-
fered from those in PPNG with TEM-1. Although all PPNG iso-
lates were susceptible to ceftriaxone and cefixime, the MIC50 
and MIC90 of both antibiotics were much lower in PPNG with 
TEM-135 (both values ≤0.008 μg/mL) than in PPNG with TEM-1 
(0.03 μg/mL and 0.12 μg/mL, respectively). The rate of azithro-
mycin-susceptible isolates was 100% in TEM-135 strains, but 
60% in TEM-1 strains. The MIC50 of tetracycline in TEM-135 
and TEM-1 PPNG was 0.5 μg/mL and 4 μg/mL, respectively, 
and the rates of resistance were 30.8% and 78.1%, respec-
tively. Although a previous study conducted in England utilizing 
a similar approach discovered statistically higher ciprofloxacin 
and tetracycline MIC values in TEM-135 strains [14], our results 
do not support such trends. However, they may suggest clonal 
relatedness consisting of isolates highly susceptible to ceftriax-
one and cefixime that can be discriminated from TEM-1 PPNG, 
despite the high selective pressure of ceftriaxone usage in Korea.
This hypothesis can be partially supported by our phylogenetic 
and plasmid analyses. The phylogenetic tree based on partial 
porB sequences revealed that some of the TEM-135 isolates 
appear to be closely related in terms of genetic distances and 
recent isolation within the last three years (Cluster A and B; Fig. 
2). However, the other genetically dispersed TEM-135 PPNG 
isolates were also highly susceptible to ceftriaxone and cefixime, 
which may suggest that TEM-135 PPNG isolates originated in a 
low ceftriaxone selective pressure environment (similar to tetra-
cycline-resistant N. gonorrhoeae [TRNG] that has increased re-
cently in Korea [18]), compared with TEM-1 PPNG, which is 
less susceptible to ceftriaxone and cefixime. 
The predominance of the Toronto/Rio plasmid type in TEM-
135 PPNG revealed in our study is in line with previous epide-
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miological studies conducted in other countries [10, 15, 16, 19], 
although only one study from England reported the predomi-
nance of the Asian plasmid type [14]. Therefore, we assume 
that a specific plasmid (Toronto/Rio) has been distributed world-
wide. The ceftriaxone and cefixime MIC values of isolates with 
an Asian plasmid type (0.06 μg/mL, respectively) were higher 
than the values of isolates with other plasmid types; however, 
the number of isolates was too small to draw any definitive con-
clusions. 
A recent report identified four novel TEM alleles from globally 
collected strains [19]; we did not identify any new TEM alleles 
other than TEM-1 and TEM-135. Interestingly, all isolates in this 
study had a thymidine instead of cytosine at nucleic acid posi-
tion 18 compared with the previously reported blaTEM-135 refer-
ence sequence from Thailand (GenBank accession number: 
GQ896333). However, a comparison of our sequences with N. 
gonorrhoeae TEM-1 and TEM-220 sequences revealed that thy-
midine at position 18 is common (Table 1). Moreover, the bla-
TEM-135 sequence in Salmonella enterica subsp. enterica serovar 
Typhimurium, in which TEM-135 was first identified, was identi-
cal to that of all our TEM-135-harboring isolates. This sequence 
is also identical to the sequences of the first TEM-135 isolates 
reported in Japan [17]. Thus, the TEM-135 PPNG isolates from 
our study might be more closely related to the original Japanese 
TEM-135 isolates than to the previously reported reference strain. 
Furthermore, the clonal relatedness of TEM-135 strains only 
became prominent in the last three years, suggesting the possi-
bility of foreign acquisition.
In conclusion, the proportion of TEM-135 PPNG has continu-
ously increased during the past four years and most of the iso-
lates are highly susceptible to ceftriaxone and cefixime despite 
the high selective pressure of ceftriaxone usage in Korea. The 
recent increase in TEM-135 PPNG proportion is associated with 
clonal spread; however, we hypothesize that most of the isolates 
have originated from relatively low ceftriaxone selective pressure 
environments. Moreover, the difference at position 18 of the 
TEM-135 sequence can be interpreted as the presence of at 
least two clonal complexes, one of which is thought to be asso-
ciated with the Japanese sequence, even though direct connec-
tion cannot be proved. The possibility of foreign import requires 
rigorous follow-up to control the foreign acquisition of novel re-
sistance and continuous monitoring of TEM-135 to elucidate 
whether TEM-135 constitutes a step towards evolutionary change 
of resistance to prevent the dissemination.
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Supplemental Data Table S1. Comparison of resistance proportion and antibiotic geometric mean MIC values according to the presence 
of TEM-1 or TEM-135 during the years 2006–2010 and 2011–2015
Antibiotics
2005–2010 2011–2015
MIC (µg/mL) MIC (µg/mL)
Range MIC50 MIC90 Range MIC50 MIC90
TEM-1 PPNG (N=38)* N=19 N=19
Penicillin 4–256 64 128 2–256 128 256
Ceftriaxone ≤0.008–0.12 0.03 0.12 ≤0.008–0.06 0.03 0.06
Cefixime ≤0.008–0.12 0.03 0.12 ≤0.008–0.25 0.03 0.06
Spectinomycin 16–32 32 32 16–32 32 32
Tetracycline 0.25–32   2 16 0.25–128 32 64
Ciprofloxacin 0.06–4   2   4 1–32   4   8
Azithromycin ≤0.06–1 0.5   1 ≤0.06–8 0.5   1
TEM-135 PPNG (N=14)† N=4 N=10
Penicillin 128 128 128 32–256 128 128
Ceftriaxone ≤0.008 ≤0.008 ≤0.008 ≤0.008–0.06 ≤0.008 0.06
Cefixime ≤0.008–0.015 ≤0.008 0.015 ≤0.008–0.06 ≤0.008 0.06
Spectinomycin 16–32 16 32 8–32 32 32
Tetracycline 0.5–16 0.5 16 0.25–32 0.5 32
Ciprofloxacin ≤0.008–2 2   2 ≤0.008–8 2   4
Azithromycin‡ ≤0.06–0.25 0.06 0.25 ≤0.06–0.25 0.06 0.25
Non-PPNG (N=529) N=238 N=291
Penicillin ≤0.06–8 1 2 ≤0.06–128 1 4
Ceftriaxone ≤0.008–0.25 0.03 0.12 ≤0.008–1 0.03 0.12
Cefixime ≤0.008–0.5 0.03 0.12 ≤0.008–4 0.03 0.25
Spectinomycin ≤4–32 32 32 8–64 32 32
Tetracycline ≤0.12–64   2 16 ≤0.12–128   2 32
Ciprofloxacin ≤0.008–64   8 16 ≤0.008–64   8  32
Azithromycin‡ ≤0.06–1 0.5   1 ≤0.06–4 0.25 0.5
*Of the 56 TEM-1 PPNG isolates, 38 isolates were available for antimicrobial susceptibility testing with all seven antibiotics; †Of the 16 TEM-135 PPNG iso-
lates, 14 isolates were available for antimicrobial susceptibility testing with all seven antibiotics; ‡EUCAST cut-off values were utilized because there are no 
recommended cut-off values in CLSI M100-S25.
Abbreviations: MIC, minimum inhibitory concentration; MIC50, median MIC; MIC90, 90% MIC; PPNG, penicillinase-producing N. gonorrhoeae.
